-
Mashup Score: 17Effect of Evolocumab and Statin on Coronary Plaque After MI - American College of Cardiology - 2 year(s) ago
Dustin D Spencer, PharmD
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Ethnicity-Dependent Performance of the GRACE Risk Score - American College of Cardiology - 2 year(s) ago
Debabrata Mukherjee, MD, FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A new study found that ethnic minority patients with #NSTEMI were younger and exhibited increased cardiometabolic risk factor profiles. Read more: https://t.co/urvUjmQNob #cvMetabolic #cvACS
-
-
Mashup Score: 6Acute Myocardial Infarction After Surgical Closure of Coronary Artery Fistula: Importance of Anticoagulant Therapy - 2 year(s) ago
Abstract We present a case of a coronary arteriovenous fistula between the left circumflex (LCX) and the atrium with LCX ectasia. Four months after surgical closure of the fistula, the patient expe…
Source: JACC: Case ReportsCategories: Expert Picks, Latest HeadlinesTweet-
#JACCCaseReports #WednesdayAnswer: DPI (OAC plus SAPT) Despite lack of evidence in the field, DPI (OAC plus SAPT) was preferred in this case as the patient experienced #NSTEMI 4 weeks after surgery while on SAPT regimen. https://t.co/ApOialr4Hm #CardioTwitter #CardioEd #cvCAD https://t.co/hlb6n2Rpkk
-
-
Mashup Score: 4For Best Results in ACS PCI: Treat Upstream With P2Y12 Inhibitors - American College of Cardiology - 2 year(s) ago
Quick Takes Pre-treatment with a P2Y12 inhibitor reduces cardiovascular events in the ACS population. The benefit of pre-treatment is time dependent and increases with the length of time between pre-treatment and the cath lab. In healthcare systems where NSTEMI patients are not routinely taken to the cath lab within the first few hours of presentation early treatment is an important component of…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Pre-treatment with a P2Y12 inhibitor could reduce cardiovascular events in the #cvACS population. Read the expert analysis to learn more: https://t.co/4sRfx8Sz72 #CathLab #NSTEMI #PCI
-
-
Mashup Score: 1Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST‐Segment–Elevation Myocardial Infarction - 2 year(s) ago
Background The role of invasive management compared with medical management in patients with non–ST‐segment–elevation myocardial infarction (NSTEMI) and advanced chronic kidney disease (CKD) is unc…
Categories: Cardiologists, Latest HeadlinesTweet-
In a propensity-score matched analysis of @AHRQNews data by Majmundar et al. in patients with #NSTEMI and #CKD, we report invasive management being associated with lower mortality, #MACE, #MI, and revascularization at 6 months in #CKD stages 3–5 and #ESRD: https://t.co/6rk2Ngu6ur https://t.co/zfcq1EynBf
-
-
Mashup Score: 0
With four trials cementing the futility of early imaging in NSTEMI OHCA, the next challenge is to look for any subgroup benefits.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
EMERGE Trial : Early #Angiography Doesn’t Boost OHCA Survival After #NSTEMI With four trials cementing the futility of early imaging in NSTEMI OHCA, the next challenge is to look for any subgroup benefits. @TCTMD @TCTMD_Caitlin @ShelleyWood2 @mmamas1973 https://t.co/XQse9DDnBL
-
-
Mashup Score: 2
The elderly constitute a major proportion of patients admitted with acute coronary syndrome (ACS) in the US. Due to pre-existing comorbidities, frailty, and increased risk of complications
Source: www.uscjournal.comCategories: Cardiologists, Latest HeadlinesTweet-
Tq, @radcliffeCARDIO for the opportunity to contribute to this review on ‘Age Considerations in Invasive Mx of #ACS’! For Rx of elderly pts w/ ACS, imp to consider several clinical issues including QOL, goals of care, etc! #STEMI #NSTEMI #UNMCIM Link 👉 https://t.co/pLF7xdChek https://t.co/lusqV4tVyb
-
-
Mashup Score: 0
Background: Sex differences in clinical characteristics and in-hospital outcomes among patients with non–ST-segment–elevation myocardial infarction have been described in Western countries, but wheth
Categories: Cardiology News and Journals, Latest HeadlinesTweet-
#JustPublished: #OriginalResearch from @guo_weihong et al in #CircCQO: Sex Differences in Characteristics, Treatments & Outcomes among Patients Hospitalized for #NSTEMI in China: 2006-2015 📖Learn more: https://t.co/oqgz4C0NJz #AHAJournals https://t.co/CFxHdiCC2s
-
-
Mashup Score: 2Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials - 2 year(s) ago
AbstractAims. The optimal timing of an invasive strategy (IS) in non-ST-elevation acute coronary syndrome (NSTE-ACS) is controversial. Recent randomized control
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Is there evidence of a benefit in clinical outcomes of early versus delayed invasive coronary angiography strategies in patients with NSTE-ACS? https://t.co/D5nzg3gWpo #NSTEMI #ACS #invasive #timing #PCI #mortality #cardiotwitter @escardio @ESC_Journals https://t.co/oGMhUTFtkd
-
-
Mashup Score: 5
This editorial refers to ‘Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials’, by T.A. Kit
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Timing of invasive management of NSTE-ACS: is the time up for early management? https://t.co/VUTAczfwmy #NSTEMI #ACS #GRACE #score #RCT #hsTn #cardiotwitter @escardio @ESC_Journals https://t.co/weXe5U9mp5
-
Evolocumab, in combination w/ #Statin therapy, produces atheroma stabilization and regression following an #NSTEMI demonstrating a potential mechanism for improved clinical outcomes for patients with very low LDL-C levels. Read more: https://t.co/pfALl6s6Mm #cvACS #Cholesterol